Biochemical and molecular studies of human methenyltetrahydrofolate synthetase

Stem Cells

Volumn 14, Issue 1, 1996, Pages 33-40

  Jolivet, Jacques ^a   Dayan, Alain ^a   Beauchemin, Myriam ^a   Chahla, Dounia ^a   Mamo, Aline ^a   Bertrand, Richard ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

5 fluorouracil; Folate metabolism; Leucovorin

Indexed keywords

5 FORMYLTETRAHYDROFOLATE CYCLOLIGASE; COMPLEMENTARY DNA; DIHYDROFOLATE REDUCTASE; FLUOROURACIL; FOLINIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; SYNTHETASE; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; COLORECTAL CARCINOMA; CYTOSOL; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME CHEMISTRY; ENZYME KINETICS; FOLATE METABOLISM; HUMAN; MITOCHONDRION; MOLECULAR WEIGHT; NONHUMAN; REVIEW;

EID: 0030053523     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140033     Document Type: Review

References (55)

1. Grem JL, Hoth DF, Hamilton JM et al. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep 1987;71:1249-1264.
2. Jolivet J, Cowan KH, Curt GA et al. The pharmacology and clinical use of methotrexate. N Engl J Med 1983;309:1094-1104.
3. Stover P, Schirch V. The metabolic role of leucovorin. Trends Biochem Sci 1993;18:102-106.
4. Kisliuk RL. In: Folate antagonists as therapeutic agents, Sirontnak FM, Burchall JJ, Ensminger WB et al., eds. Orlando. Academic Press 1984:2-68.
5. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 1989;45:263-335.
6. MacKenzie RE. In: Folates and pterins, Blakely RL, Benkovic SJ, eds. New York: John Wiley and Sons 1984;1:255-306.
7. Appling DR. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 1991;5:2645-2651.
8. Chasin LA, Feldman A, Konstam M et al. Reversion of a Chinese hamster cell auxotrophic mutant. Proc Natl Acad Sci USA 1974;71:718-722.
9. Heidelberger C, Danenberg PV, Moran RG. In: Meister A, ed. Advances in Enzymology and Related Areas in Molecular Biology. New York. John Wiley and Sons, 1983:57-119.
10. Lockshin A, Danenberg PV. Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. Biochem Pharmacol 1981;30:247-251.
11. Radparvar S, Houghton PJ, Houghton JA. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2′-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft. Biochem Pharmacol 1989;38:335-342.
12. Romanini A, Lin JT, Niedzwiecki D et al. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin. Cancer Res 1991;51:789-793.
13. Schuetz JD, Wallace HJ, Diasio RB. DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells. Cancer Chemother Pharmacol 1988;21:208-210.
14. Spears CP, Gustavsson BG, Berne M. Cancer Res 1988:5894-5900.
15. Leichman CG, Lenz HJ, Leichman L et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer resistance to protracted infusion 5-fluorouracil and weekly leucovorin. Proc Annu Meet Am Soc Clin Oncol 1994:2.
16. Johnston PG, Lenz HJ, Leichman CG et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-1412.
17. Ullman B, Lee M. Martin DW et al. Cytotoxicity of 5-fluoro-2′-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 1978;75:980-983.
18. Evans RM, Laskin JD, Hakala MT. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 1981;41:3288-3295.
19. van der Wilt CL, Peters GJ. New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: thymidylate synthase Pharm World Sci 1994;16:84-103.
20. Cosulish DB, Smith JM, Broquist HP. Diastereomer of leucovorin. J Am Chem Soc 1952;74:4215-4216.
21. Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
22. Straw JA, Szapary D, Wynn WT. Pharmacokinetics of the diastereomers of leucovorin after intravenous and oral administration to normal subjects. Cancer Res 1984;44:3114-3119.
23. Schilsky RL, Ratain MJ. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration. J Natl Cancer Inst 1990;82:1411-1415.
24. Priest DG, Schmitz JC, Bunni MA et al. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. J Natl Cancer Inst 1991;83:1806-5812.
25. Newman EM, Akman SA, Harrison JS et al. Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer. Cancer Res 1992;52:2408-2412.
26. Bertrand R, Jolivet J. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations. J Natl Cancer Inst 1989;81:1175-1178.
27. McGuire JJ, Russell CA. Biological and biochemical properties of the natural (6S) and unnatural (6R) isomers of leucovorin and their racemic (6R,S) mixture. J Cell Pharmacol 1991;2:317-323.
28. Zhang ZG, Rustum YM. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2′-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells. Cancer Res 1991;51:3476-3481.
29. Zittoun J, Marquet J, Pilorget JJ et al. Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil. Br J Cancer 1991;63:885-888.
30. Voeller DM, Allegra CJ. Intracellular metabolism of 5-methyltetrahydrofolate and 5-formyltetrahydrofolate in a human breast-cancer cell line. Cancer Chemother Pharmacol 1994;34:491-496.
31. Houghton JA, Williams LG, de Graaf SN et al. Comparison of the conversion of 5-formyltetrahydrofolate and 5-methyltetrahydrofolate to 5,10, methylenetetrahydrofolate and tetrahydrofolates in human colon tumors. Cancer Commun 1989;1:167-174.
32. Etienne MC, Fischel JL, Formento P et al. Combination of reduced folates with methotrexate or 5-fluorouracil. Comparison between 5-formyltetrahydrofolate (folinic acid) and 5-methyltetrahydrofolate in vitro activities. Biochem Pharmacol 1993;46:1767-1774.
33. Mader RM, Steger GG, Rizovski B et al. Different stereospecific protein binding of tetrahydrofolates to human serum albumin. J Pharm Sci 1994;83:1247-1249.
34. Mullin RJ, Keith BR, Duch DS. Distribution and metabolism of calcium leucovorin in normal and tumor tissue. Adv Exp Med Biol 1988;244:25-38.
35. Houghton JA, Williams LG, Cheshire PJ et al. Influence of dose of [6rs]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts. Cancer Res 1990;50:3940-3946.
36. Houghton JA, Williams LG, de Graft SS et al. Relationship between dose rate of [6rs]leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts. Cancer Res 1990;50:3493-3502.
37. Boarman DM, Allegra CJ. Intracellular metabolism of 5-formyl tetrahydrofolate in human breast and colon cell lines. Cancer Res 1992;52:36-44.
38. Lowe KE, Osborne CB, Lin BF et al. Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-gamma-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-gamma-glutamate specificity of metabolic cycles of one-carbon metabolism. J Biol Chem 1993;268:21665-21673.
39. Cichowicz DJ, Shane B. Mammalian folylpoly-gamma-glutamate synthetase. 2. Substrate specificity and kinetic properties. Biochemistry 1987;26:513-521.
40. 5-formyltetrahydrofolic acid cyclodehydrase. Biochemistry 1965;4:1872-1878.
41. Grimshaw CE, Henderson GB, Soppe GG et al. Purification and properties of 5,10-methenyltetrahydrofolate synthetase from Lactobacillus casei. J Biol Chem 1984;259:2728-2733.
42. Hopkins S, Schirch V. 5,10-methenyltetrahydrofolate synthetase. Purification and properties of the enzyme from rabbit liver. J Biol Chem 1984;259:5618-5622.
43. Bertrand R, MacKenzie RE, Jolivet J. Human liver methenyltetrahydrofolate synthetase: improved purification and increased affinity for folate polyglutamate substrates. Biochim Biophys Acta 1987;11:154-161.
44. Maras B, Stover P, Valiante S et al. Primary structure and tetrahydropteroylglutamate binding site of rabbit liver cytosolic 5,10-methenyltetrahydrofolate synthetase. J Biol Chem 1994;269:18429-18433.
45. Stover P, Schirch V. Serine hydroxymethyltransferase catalyzes the hydrolysis of 5,10-methenyltetrahydrofolate to 5-formyltetrahydrofolate J Biol Chem 1990;265:14227-14233.
46. Stover P, Schirch V. 5-formyltetrahydrofolate polyglutamates are slow tight binding inhibitors of serine hydroxymethyltransferase. J Biol Chem 1991;266:1543-1550
47. Bertrand R, Jolivet J. Methenyltetrahydrofolate synthetase prevents the inhibition of phosphoribosyl 5-aminoimidazole 4-carboxamide ribonucleotide formyltransferase by 5-formyltetrahydrofolate polyglutamates. J Biol Chem 1989;264:8843-8846.
48. 12-dependent methionine synthetase on the subcellular distribution of folate coenzymes in rat liver. Arch Bioch Biophys 1989;270:729-733.
49. Bertrand R. Beauchemin M, Dayan A et al. Identification and characterization of human mitochondrial methenyltetrahydrofolate synthetase activity. Biochim Biophys Acta 1995;1266:245-249.
50. Dayan A, Bertrand R, Beauchemin M et al. Cloning and characterization of the encoding cDNA human 5,10-methenyltetrahydrofolate synthetase. Gene 1995 (in press).
51. Frohman MA, Dush MK, Martin GR. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 1988;85:8998-9002.
52. Beauchemin N, Benchimol S, Cournoyer D et al. Isolation and characterization of full-length functional cDNA clones for human carcinoembryotic antigen. Mol Cell Biol 1987;7:3221-3230.
53. Cook RJ, Lloyd RS, Wagner C. Isolation and characterization of cDNA clones for rat liver 10-formyltetrahydrofolate dehydrogenase. J Biol Chem 1991;266:4965-4973.
54. Hsu LM, Zagorski J, Fournier M. Escherichia coli 6S RNA gene is part of a dual-function transcription unit. J Bacteriol 1985;161:1162-1170.
55. Smith CWJ, Patton JG, Nadal-Ginard B. Alternative splicing in the control of gene expression Ann Rev Genet 1989;23:527-577.